Thomas Hauser responds to USADA statements – again
Thomas Hauser says USADA’s response to his recent article “is long on verbiage and short on documented facts” in this statement to the media.
read moreUSADA responds to Thomas Hauser with 25-page document
USADA has a PDF on their website which lays out where they take offense to characterizations made by noted journalist and author Thomas Hauser.
read moreMayweather’s TUE raises questions; Pacquiao wants answers
In light of the recent Thomas Hauser piece alleging illegal IV use by Floyd Mayweather, Manny Pacquiao speaks out.
read moreDougie’s Friday mailbag
Fans comment on Thomas Hauser’s article on USADA’s role in boxing, Floyd Mayweather Jr.’s IV use prior to the Pacquiao fight; Andre Berto, other weekend fights, mythical match-ups and more in this week’s Friday mailbag.
read moreThomas Hauser issues statement with regard to USADA comments
Thomas Hauser issued a statement with regard to the recent comments by USADA spokesperson Annie Skinner on behalf of the anti-doping agency.
read moreUSADA, Floyd Mayweather Jr. issue statements responding to article
USADA and Floyd Mayweather Jr. issued statements in response to Thomas Hauser’s recent article questioning the agency’s PED-testing practices in boxing.
read moreThomas Hauser explains USADA/Mayweather article
RingTV.com’s Michael Woods contacted Thomas Hauser to ask follow-up questions about the award-winning writer’s recent article on USADA PED testing in boxing.
read moreAl Haymon’s fighters to undergo random drug testing, brain study
Just when you think boxing on free TV is a great thing, the news gets better: As part of NBC’s ‘Premier Boxing Champions’ series, fighters will undergo stringent drug-testing and brain studies.
read moreDrug-tested Marcos Maidana ‘ahead of schedule’ for Floyd Mayweather Jr.
Strength and conditioning guru Alex Ariza characterized Marcos Maidana’s first round of random drug testing with the United States Anti-Doping Agency (USADA) as being “discrete, organized, and professional” on Wednesday.
read more